VIVUS (VVUS) Peers Tick Higher Amid Positive Qsymia Data (ARNA) (OREX)

February 1, 2013 8:16 AM EST
VIVUS, Inc. (Nasdaq: VVUS) shares are ticking higher in early trading Friday morning following publication of positive results from a "study concluding that weight loss resulting from treatment with Qsymia (phentermine and topiramate extended-release) capsules CIV led to significant improvements in cholesterol, blood pressure and triglycerides in obese and overweight patients experiencing one or more of these associated conditions."

The article can be accessed here.

Also catching some positive sentiment today are VIVUS peers Arena Pharmaceuticals (Nasdaq: ARNA) and Orexigen (Nasdaq: OREX). All three are positive ahead of the bell.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment